Travelers Companies (TRV) Adds Anthony Jabbour To Its Board And Key Committees

Zacks reports that by July 24, 135 S&P 500 companies have posted Q2 2026 results, with total earnings up 67.8% year over year and revenue up 12.6%, while 87.4% beat EPS and 79.3% beat revenue estimates. It highlights three Dow blue chips with favorable Zacks Ranks: 3M (MMM), Travelers (TRV), and UnitedHealth (UNH), citing 2026 guidance and estimate revisions.

On July 24, the Dow rose 235.60 points (0.46%) to 51,947.25, while the Nasdaq fell 161.87 points (0.64%) to 24,975.82 for a third straight session. The semiconductor selloff followed Intel’s post-earnings drop of 7.89% to $92.32, dragging chip peers including Micron and AMD. Oil prices eased on Middle East peace-talk hopes.

Travelers Companies (TRV) has risen more than 30% in 2026 to record highs, supported by strong Q2 results and demand for defensive insurers. At least six analysts downgraded TRV this month, including Goldman Sachs to sell and BMO to market perform, citing valuation and limited upside. TRV trades near 12x forward earnings and 2.7x tangible book value.

Travelers Companies (TRV) shares rose about 2.8% to a 52-week high of $386.77, after its Q2 2026 results on July 17. The insurer reported core income of $2.2 billion, or $10.04 per diluted share, nearly double consensus, helped by lower catastrophe losses and higher net investment income. Analysts raised price targets, including Mizuho to $343, and Travelers returned over $1.5 billion via buybacks and dividends.

Mizuho raised its price target for Travelers Companies (NYSE:TRV) to $343 from $324 and kept a Neutral rating. It lifted 2026 EPS to $34.75, citing a Q2 earnings beat, improved underwriting for Business and Personal Insurance, and higher share-count reduction. Mizuho also increased 2027 and 2028 EPS estimates and noted an improved Business Insurance loss ratio.

Travelers Companies (NYSE:TRV) shares hit a new 52-week high, trading up to $374.00 and last at $372.6150 versus a prior close of $369.63, with about 2.48M shares traded. The move follows a July 17 earnings beat: $10.04 EPS and $12.15B revenue, plus dividend details and multiple analyst target changes.